Sex-related type of venous thromboembolism in patients with and without thrombophilia

Daniela Tormene; Sofia Barbar; Marica Perlati; Barbara Brandolin; Paolo Simioni

doi:10.1160/TH09-02-0116

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2009; 102(01): 177-178
DOI: 10.1160/TH09-02-0116

Letters to the Editor

Schattauer GmbH

Sex-related type of venous thromboembolism in patients with and without thrombophilia

Daniela Tormene

¹Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Italy

,

Sofia Barbar

¹Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Italy

,

Marica Perlati

¹Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Italy

,

Barbara Brandolin

¹Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Italy

,

Paolo Simioni

¹Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Turkstra F, Karemaker R, Kuijer PM. et al. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?. Thromb Haemost 1999; 81: 345-348.
2 Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 2000; 356: 182-183.
3 Margaglione M, Brancaccio V, De Lucia D. et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000; 118: 1405-1411.
4 Rossi E, Za T, Ciminello A. et al. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia. Thromb Haemost 2008; 99: 1030-1034.
5 Dentali F, Gianni M. VTE recurrence in patients with inherited deficiencies of natural anticoagulants. Thromb Haemost 2009; 101: 5-6.
6 Kyrle PA, Minar E, Bialonczyk C. et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558-2563.
7 Christiansen SC, Cannegieter SC, Koster T. et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-2361.
8 Simioni P, Sanson BJ, Prandoni P. et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
9 Simioni P, Tormene D, Prandoni P. et al. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood 2002; 99: 1938-1942.
10 Simioni P, Tormene D, Manfrin D. et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol 1998; 103: 1045-1050.
11 Zanon E, Saracino MA, Simioni P. et al. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant. Clin Lab Haematol 1995; 17: 231-235.
12 Koeleman BP, Reitsma PH, Bertina RM. Familial thrombophilia: a complex genetic disorder. Semin Hematol 1997; 34: 256-264.
13 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.